IONQ · IonQ, Inc.

The thesis

IonQ has raised about $2.0 billion in new equity and agreed to a stock-funded $1.3 billion Cybersecurity acquisition, but the shares closed at $31.16 on 22 October 2026, so the market is pricing the dilution ahead of the benefits. The third-quarter 2026 report, expected around 5 November 2026, settles whether consolidated revenue still supports the $450–460 million full-year outlook.

The narrative is maturing and the news flow has turned from contracts to financing: the DARPA Stage C announcement on 7 October 2026 was followed by the 12 October 2026 Elisity deal and the 14 October 2026 offering. The shares have fallen 13.3% over three months, and the 14-day relative strength index, a 0–100 momentum gauge, reads 22.6, below the conventional 30 line for oversold. The rating stays low: the new cash and the DARPA award are real, but the share price has not confirmed them.

Bullish and bearish views on IonQ, Inc.

The bull case on IonQ, Inc. (IONQ), in brief: The balance sheet just got much larger. The bear case: Dilution is large.

Bull case

• The balance sheet just got much larger. IonQ's prospectus supplement dated 14 October 2026 shows gross proceeds of about $1.999997 billion, with settlement expected on 16 October 2026. The company says the money is for working capital and general corporate purposes, and possibly acquisitions and partnerships.
• DARPA advanced IonQ to its final stage. IonQ announced on 7 October 2026 that it reached Stage C of DARPA's Quantum Benchmarking Initiative under an agreement worth up to $300 million through 2029. The $300 million is a maximum value.
• Revenue has a measured starting point. IonQ reported second-quarter 2026 revenue of $80.05 million, up 287% year over year, with 132% organic growth, on 5 August 2026. Full-year 2026 revenue guidance of $450–460 million was filed on 8 September 2026.
• Most sell-side targets sit well above the price. Rosenblatt kept a Buy rating on 15 October 2026 and lowered its target to $70. Bank of America Securities' Buy rating carries a $60 target, and Needham ($65), Cantor Fitzgerald ($70) and Benchmark ($60) reiterated targets on 6 August 2026.
• Elisity extends the security story. IonQ's 8-K says the all-stock Elisity acquisition is valued at up to $1.3 billion and is expected to close in the fourth quarter of 2026. IonQ said on 6 August 2026 that customer conversations were shifting toward protection against quantum threats.

Bear case

• Dilution is large. The 14 October 2026 prospectus supplement covers 20.5 million common shares, 29.5 million pre-funded warrants and 100 million Series C warrants exercisable at $69.46. It registers 129.5 million shares issuable on exercise.
• The Elisity deal adds more stock. IonQ said on 14 October 2026 that it will issue $1.15 billion in shares for Elisity, priced between $33.07 and $49.61, plus up to $150 million in earnout shares and $100 million in employee restricted stock units. The 22 October 2026 close of $31.16 is below the lower end of that range.
• The price reacted badly. Quantum Computing Report put the 13 October 2026 close at $34.78, and MarketBeat reported a drop of about 9% after the acquisition and offering news. The 22 October 2026 close was $31.16.
• Analysts are trimming. On 15 October 2026 Morgan Stanley kept Equal-Weight and lowered its target to $43, and Rosenblatt lowered its target to $70.
• Losses and the revenue bridge remain open. IonQ's 5 August 2026 results showed a $120.3 million adjusted loss before interest, taxes, depreciation and amortization. The $450–460 million outlook includes SkyWater from 31 July 2026 and estimated intercompany eliminations, and IonQ has not quantified acquired versus organic revenue.

Price setup

The last adjusted close was $31.16 on 22 October 2026. The 52-week high is $72.07, which puts the shares 56.8% below it. The 14-day relative strength index is 22.6.

The prior note's recovery level was a weekly close of $36. The closes of $34.78 on 13 October 2026 and $31.16 on 22 October 2026 both sit below it, so the September repair has been undone.

Crowding evidence points two ways. Retail-oriented headlines continued through 19 October 2026 and 22 October 2026. An earnings date is about two weeks away.

Catalysts, next 30 days

• ~5 November 2026, est.: Third-quarter 2026 results. IonQ has not confirmed the date; an earnings calendar lists 5 November 2026 after the close. It is the first report with a full SkyWater quarter and shows whether the outlook holds.
• By 31 December 2026, expected: Elisity closing. IonQ's 8-K expects completion in the fourth quarter, subject to regulatory approvals. The closing sets the final share count within the $33.07–$49.61 range.

What would change the view

The case breaks if the third-quarter report cuts the $450–460 million full-year revenue outlook, or if acquired and intercompany revenue are not separated from organic revenue. It also breaks if the Elisity deal fails to close or is repriced. On price, a daily close below $28 would extend the decline that followed the 14 October 2026 offering.

The case improves if the report shows organic growth continuing from the 132% reported for the second quarter. It also improves if IonQ discloses a meaningful initial obligated amount under the DARPA Stage C agreement.

What it trades with

IonQ trades with other listed Quantum computing companies and with high-growth technology shares, so moves in the Nasdaq 100 carry through to it. The Nasdaq 100 fell on 12 October 2026 as the artificial-intelligence trade faltered, the day the Elisity deal was announced. Its SkyWater ownership ties part of the consolidated revenue to semiconductor manufacturing, and Elisity would add a Cybersecurity software line.